Home
| Log in or Sign Up for full access
| Tracked Organizations
| Recent Tracked Activities
Recent Activities
Activities between Nov. 16, 2024, 12:42 a.m. and Nov. 23, 2024, 12:42 a.m.
from: Urgent Care Clinics.
Click on a document link to see the original source document.
Click on the name of an organization to see more organization linkages and timelines.
Document Date: Nov. 21, 2024, 3:45 p.m. / Source: Fierce Biotech
Activity Class: PartnershipActivity
Partnership:
Document Extract: Through a collaboration with MD Anderson Cancer Center and Su Clinica, a federally qualified health center, the company described the pilot program as the first of its kind, spanning locations in Brownsville, Harlingen, Raymondville and Santa Rosa. " Not only can cervical cancer be prevented, with greater access to vaccines and screening, we have a real opportunity to eliminate this disease as a public health problem in our lifetimes ," Su Clinica CEO Elena Marin said in a statement. " Women in our region are disproportionately affected by cervical cancer, both in terms of rates and mortality, so there is an urgent need to remove barriers to potentially life-saving screening, and self-collection is a pivotal solution ," Marin added. " Having a test that is safe, private, and easy to use will go a long way towards increasing cancer screening rates for those who may be hesitant or unable to receive a traditional screening ." BD's Onclarity HPV assay received an FDA approval in May, alongside a test developed by Roche, that allows women to skip the traditional Pap smear exam.
Document Source: https://www.fiercebiotech.com/medtech/bd-teams-md-anderson-su-clinica-study-hpv-self-collection-tests-underserved-texas
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 3:45 p.m. / Source: Fierce Biotech
Activity Class: PartnershipActivity
/ Region: Texas
Partnership:
- BD
/ Industry: Hypromag Has Licensed The Patented Technology Called Hpms
- MD Anderson, Su Clinica
/ Industry: Urgent Care Clinics
Document Extract: BD teams up with MD Anderson, Su Clinica to study HPV self-collection tests in underserved Texas communities. After collecting an FDA greenlight earlier this year, BD is launching a real-world study to see if its self-collection kits for HPV testing will improve cervical cancer screening rates among underserved communities in southern Texas. Through a collaboration with MD Anderson Cancer Center and Su Clinica, a federally qualified health center, the company described the pilot program as the first of its kind, spanning locations in Brownsville, Harlingen, Raymondville and Santa Rosa. " Not only can cervical cancer be prevented, with greater access to vaccines and screening, we have a real opportunity to eliminate this disease as a public health problem in our lifetimes ," Su Clinica CEO Elena Marin said in a statement. " Women in our region are disproportionately affected by cervical cancer, both in terms of rates and mortality, so there is an urgent need to remove barriers to potentially life-saving screening, and self-collection is a pivotal solution ," Marin added.
Document Source: https://www.fiercebiotech.com/medtech/bd-teams-md-anderson-su-clinica-study-hpv-self-collection-tests-underserved-texas
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 3:45 p.m. / Source: Fierce Biotech
Activity Class: PartnershipActivity
Partnership:
Document Extract: After collecting an FDA greenlight earlier this year, BD is launching a real-world study to see if its self-collection kits for HPV testing will improve cervical cancer screening rates among underserved communities in southern Texas. Through a collaboration with MD Anderson Cancer Center and Su Clinica, a federally qualified health center, the company described the pilot program as the first of its kind, spanning locations in Brownsville, Harlingen, Raymondville and Santa Rosa. " Not only can cervical cancer be prevented, with greater access to vaccines and screening, we have a real opportunity to eliminate this disease as a public health problem in our lifetimes ," Su Clinica CEO Elena Marin said in a statement. " Women in our region are disproportionately affected by cervical cancer, both in terms of rates and mortality, so there is an urgent need to remove barriers to potentially life-saving screening, and self-collection is a pivotal solution ," Marin added. " Having a test that is safe, private, and easy to use will go a long way towards increasing cancer screening rates for those who may be hesitant or unable to receive a traditional screening ."
Document Source: https://www.fiercebiotech.com/medtech/bd-teams-md-anderson-su-clinica-study-hpv-self-collection-tests-underserved-texas
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 7:15 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: Texas
Partnership:
Document Extract: HPV is the cause of virtually all cervical cancers. BD, The University of Texas MD Anderson Cancer Center and Su Clinica have announced a first-of-its-kind HPV self-collection pilot program aimed at improving cervical cancer screening in underserved communities has officially launched in Texas. The study is being conducted at Su Clinica, a Federally Qualified Health Center (FQHC) with locations in Brownsville, Harlingen, Raymondville, and Santa Rosa, Texas, together with researchers at The University of Texas MD Anderson Cancer Center. This study will evaluate the implementation and effectiveness of self-collected HPV testing in a real-world health care setting. It also aims to identify any challenges and solutions for cervical cancer screening in communities with limited access to health care resources.
Document Source: https://www.prnewswire.com/news-releases/first-of-its-kind-hpv-self-collection-study-launched-to-improve-cervical-cancer-screening-in-underserved-communities-302311969.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, noon / Source: GlobeNewswire
Activity Class: PartnershipActivity
Partnership:
Document Extract: Trawick International Enhances Global Medical Coverage with Access to Cleveland Clinic World-Renowned Care. MIAMI, Nov. 21, 2024 (GLOBE NEWSWIRE) - Trawick International, a leading global insurance provider, announces that they are working together with Cleveland Clinic, a world-renowned healthcare institution recognized for its excellence in medical specialties such as cardiology and cardiovascular surgery. Policyholders of Trawick International's Plan VIVA, as well as customers of GlobalMex and Trawick International's United Kingdom and European international private medical insurance plans, now have access to Cleveland Clinic's Global Patient Services program. Insured members will enjoy the benefits of coordinated care tailored to their unique needs, including assistance with appointment scheduling, interpretation services, and guidance throughout their treatment journey. Cleveland Clinic's Global Patient Services team is dedicated to ensuring a seamless experience for international patients before, during, and after their visit.
Document Source: https://www.globenewswire.com/news-release/2024/11/21/2985081/0/en/Trawick-International-Enhances-Global-Medical-Coverage-with-Access-to-Cleveland-Clinic-World-Renowned-Care.html
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 5:01 p.m. / Source: PR Newswire
Activity Class: LocationActivity
/ Type: Added
Location_Added_By:
Location:
Document Extract: Options Medical Weight Loss Expands to Charlotte Metro Area with New State-of-the-Art Clinic.
Document Source: https://www.prnewswire.com/news-releases/options-medical-weight-loss-expands-to-charlotte-metro-area-with-new-state-of-the-art-clinic-302310324.html
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 6 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: San Francisco
Partnership:
Document Extract: SAN FRANCISCO, Nov. 20, 2024 /PRNewswire/ - Astellas Pharma U.S., Inc. (President: Mike Petroutsas, "Astellas") today announced that it has entered into an agreement with Desert Oasis Healthcare (DOHC) , a member of Heritage Provider Network, to pilot DIGITIVA™, a non-invasive digital health solution for the management of heart failure patients. In the next few weeks, eligible patients receiving care with DOHC will begin using DIGITIVA as a new method for managing their heart health while working in partnership with their healthcare team. DIGITIVA™ is a non-invasive digital health solution for the management of heart failure patients. DIGITIVA was designed with the goal of improving heart failure management by providing patients with the CORE 500™ Digital Stethoscope developed by Eko Health Inc. and an easy-to-use smartphone app built on the Welldoc, Inc. platform, with AI-driven personalized digital coaching, as well as educational resources from the American Heart Association. Clinicians also receive tailored patient reports assessed by a clinical review team, highlighting relevant cardioacoustic biomarkers, such as S3 sounds and EMAT (electromechanical activation time) , as well as physiological parameters with the goal of enabling earlier intervention when needed.
Document Source: https://www.prnewswire.com/news-releases/astellas-announces-desert-oasis-healthcare-as-first-health-system-to-implement-digitiva-for-heart-failure-management-302311808.html
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 6 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: San Francisco
Partnership:
Document Extract: Astellas Announces Desert Oasis Healthcare as First Health System to Implement DIGITIVA™ for Heart Failure Management. SAN FRANCISCO, Nov. 20, 2024 /PRNewswire/ - Astellas Pharma U.S., Inc. (President: Mike Petroutsas, "Astellas") today announced that it has entered into an agreement with Desert Oasis Healthcare (DOHC) , a member of Heritage Provider Network, to pilot DIGITIVA™, a non-invasive digital health solution for the management of heart failure patients. In the next few weeks, eligible patients receiving care with DOHC will begin using DIGITIVA as a new method for managing their heart health while working in partnership with their healthcare team. DIGITIVA™ is a non-invasive digital health solution for the management of heart failure patients. DIGITIVA was designed with the goal of improving heart failure management by providing patients with the CORE 500™ Digital Stethoscope developed by Eko Health Inc. and an easy-to-use smartphone app built on the Welldoc, Inc. platform, with AI-driven personalized digital coaching, as well as educational resources from the American Heart Association.
Document Source: https://www.prnewswire.com/news-releases/astellas-announces-desert-oasis-healthcare-as-first-health-system-to-implement-digitiva-for-heart-failure-management-302311808.html
(archive.org page /
archive.org listing)
Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.
Treat sameAsNameOnly relationship as same? No
(Turn On)
Site Stats
| About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License.
Please send an email if you need a non-share-alike license and/or you need API access.